Understanding different types of ADHD in children to improve treatment.
Integration of markers across physiologic, behavioral, and self-report levels at baseline and in response to treatment to characterize novel subtypes in youth with ADHD
This study is looking at different traits of ADHD in kids by combining information from their bodies, behaviors, and what they say, to find specific types of ADHD that can help create better and more personalized treatments for them.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Stanford University NIH-funded |
| Lab location | 1 site (Stanford, United States) |
| Project ID | NIH-10669109 on NIH RePORTER |
What this research studies
This research aims to explore the various characteristics of Attention-Deficit/Hyperactivity Disorder (ADHD) in children by integrating information from physiological, behavioral, and self-reported measures. The goal is to identify distinct subtypes of ADHD that can lead to more personalized and effective treatment strategies. By analyzing multidimensional data, the research seeks to move beyond traditional symptom rating scales, which often fail to capture the complexity of the disorder. This approach will help in developing objective measures that can guide treatment decisions and improve outcomes for children with ADHD.
Who could benefit from this research
Good fit: Ideal candidates for this research are children aged 0-11 years who have been diagnosed with ADHD or exhibit symptoms of the disorder.
Not a fit: Patients who do not have ADHD or are outside the age range of 0-11 years may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to more tailored and effective treatment options for children with ADHD, enhancing their overall functioning and quality of life.
How similar studies have performed: Previous research has shown promise in using multidimensional data to better understand ADHD, indicating that this approach could lead to significant advancements in treatment.
Where this research is happening
Stanford, United States
- Stanford University — Stanford, United States (Active)
Researchers
- Principal investigator: Leikauf, John — Stanford University
- Study coordinator: Leikauf, John
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.